A historic opioid trial highlights what we know about the deadly drugs

Johnson & Johnson must pay $572 million to Oklahoma for the company’s role in the epidemic

Opioid pills

The judgement to hold a pharmaceutical company responsible for the opioid crisis may signal a potential reckoning for the opioid industry.

BackyardProduction/iStock/Getty Images Plus

There are no real winners in the opioid epidemic. But on August 26, a judge in Oklahoma handed a small victory to the state, which had sued opioid-maker Johnson & Johnson for its role in the morass.